Table 1.
Comparison of the tumor growth rate in young and aged mice.
Cell Lines | Young Group Age | Old Group Age | Mouse Strain | Number of Cells Injected | Injection Site | Tumor Growth in Old vs Young | References |
---|---|---|---|---|---|---|---|
B16/F10 | 2.5–6 months | 19–26 months | C57/BL/6 | 500,000 | Intradermal |
![]() |
Padrón et al., 2018 [58] |
BSC9AJ2 | 8–10 weeks | 10 months | C57BL/6 | 100,000 | Intradermal |
![]() |
Kugel et al., 2018 [64] |
4T1 | 8–10 weeks | >12 months | Balb/C | 100,000 | Mamarry fatpad |
![]() |
Sceneay et al., 2019 [91] |
Met1 | FVB | 200,000 |
![]() |
||||
AE17 | 3 months | 20–24 months | C57BL/6 | 500,000 | Subcutaneous |
![]() |
Duong et al., 2018 [113] |
TS/A | 2 months | 12 months | BXD12 | 150,000 | Subcutaneous |
![]() |
Grizzle et al., 2007 [132] |
B16/F10 | 2–6 months | 22–26 months | C57BL/6 | 250,000 | Subcutaneous |
![]() |
Hurez et al., 2012 [134] |
MC38 | 1,000,000 | ||||||
B16/F10 | 3 months | 24 months | C57BL/6 | 100,000 | Subcutaneous |
![]() |
Ershler et al., 1984 [139] |
B16/F1 | Intravenous | ||||||
B16/F10 | 4 months | 20 months | C57BL/6 | 1,000,000 | Subcutaneous |
![]() |
Reed et al., 2006 [140] |
TRAMP-C2 |
![]() |
||||||
MC38 | 3–4 months | 12–15 months | C57BL/6 | 1,000,000 | Subcutaneous |
![]() |
Oh et al., 2018 [142] |
B16/F10 | |||||||
4T1 | Balb/C | ||||||
TRAMP-C2 | 4 months | 20–24 months | C57BL/6 | 500,000 | Dorsolateral prostate |
![]() |
Bianchi-Frias et al., 2019 [143] |